Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-16

FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)

View source ↗

Summary

FDA approved the original application for duloxetine hydrochloride from Yaopharma Co., Ltd., granting approval for the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine hydrochloride (duloxetine)

Snippet

ORIG AP for DULOXETINE HYDROCHLORIDE (DULOXETINE HYDROCHLORIDE)